Diabetologia

Immune biomarkers of type 1 diabetes are many and diverse. Some of these, such as the autoantibodies, are well established but not discriminative enough to deal with the heterogeneity inherent to type 1 diabetes progression. As an alternative …

Globally, cardiovascular disease (CVD) is the leading cause of death and contributes substantially to accelerating healthcare costs [ 1 ]. Moderate to vigorous intensity physical activity (MVPA) is a key non-pharmacological strategy to reduce CVD …

In recent decades, large increases in diabetes prevalence have been demonstrated in virtually all regions of the world. The increase in the number of people with diabetes or with a longer duration of diabetes is likely to alter the disease profile …

Diabetic foot ulcers and amputations are devastating and much feared complications of diabetes. Between 15% and 34% of people with diabetes develop a foot ulcer during their lifetime, with more than half acquiring infections [ 1 ] that may result …